.slides > li:first-child { display: block; } .image__fallback { width: 100vw; display: block !important; max-width: 100vw !important; margin-bottom: 0; } .image__fallback + .hsContainer__image { display: none !important; } .hsContainer { height: auto !important; } .no-js-only { display: inherit !important; } .icon-cart.cart-button { display: none; } .lazyload, .cart_page_image img { opacity: 1; -webkit-filter: blur(0); filter: blur(0); } .bcg .hsContent { background-color: transparent; } .animate_right, .animate_left, .animate_up, .animate_down { opacity: 1; } .flexslider .slides>li { display: block; } .product_section .product_form { opacity: 1; } .multi_select, form .select { display: block !important; } .swatch_options { display: none; }

Product Data Sheet - hemaPEN

Part number: PD-1201-G

Image is representative (may not be specific item).

Download: Product Data Sheet - hemaPEN [PDF]

Also see: Part Number List - hemaPEN

hemaPEN^® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.

Share:

Collections: All, hemaPEN, hemaPEN (all), Literature - All, Literature - Health, Microsampling, Product Data Sheets, Sampling, Support Items

Category: ARTG, ARTG 280007, Australia, Australian Register of Therapeutic Goods, Blood, CE mark, Class I, Clinical, DBS, EU, FDA, Health, hemaPEN, Histology, IVD, Life, MHRA 64872, Microsampling, New Zealand, Pathology, Research, Sample collection, Sampling, Support, TGA, Therapeutic Goods Administration, UK, US FDA, US FDA D410490, USA

Type: Product Data Sheets

Related Items

Advanced precision microsampling for COVID-19 research

Advanced precision microsampling for COVID-19 research

BR-0505-G cover

Brochure - Biopsy pads

BR-0505-G_FR cover

Brochure - Biopsy Pads (French)

BR-0511-G cover

Brochure - Davidson Marking System